Screener
Vertex Pharmaceuticals VRTX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Vertex Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Vertex Pharmaceuticals’s 8-K, filed August 3, 2026. Open the filing →
- Filed
- Aug 3, 2026, 4:09 PM EDT
- Accession
- 0000875320-26-000256
FAQ
- What is Vertex Pharmaceuticals's current ratio?
- Vertex Pharmaceuticals (VRTX) reported current ratio of 3.2× in Q2 2026.
- How has Vertex Pharmaceuticals's current ratio changed year-over-year?
- Vertex Pharmaceuticals's current ratio increased by 26.4% year-over-year, from 2.5× to 3.2×.
- What is the long-term trend for Vertex Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's current ratio has grown at a -7.7% compound annual growth rate (CAGR), from 4.3× to 2.9×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Vertex Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude